🇺🇸 FDA
Patent

US 6319496

Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof

expired A61KA61K2039/51A61K39/00

Quick answer

US patent 6319496 (Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/51, A61K39/00, A61P, A61P35/00